# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Piper Sandler analyst Patrick Moley reiterates CME Gr (NASDAQ:CME) with a Overweight and maintains $225 price target.
Deutsche Bank analyst Brian Bedell maintains CME Gr (NASDAQ:CME) with a Hold and raises the price target from $193 to $200.
CME Group, the world's leading derivatives marketplace, today reported its July 2024 market statistics set a new July aver...
Deutsche Bank analyst Brian Bedell maintains CME Gr (NASDAQ:CME) with a Hold and lowers the price target from $195 to $193.
JP Morgan analyst Kenneth Worthington maintains CME Gr (NASDAQ:CME) with a Underweight and raises the price target from $187...
Keefe, Bruyette & Woods analyst Kyle Voigt maintains CME Gr (NASDAQ:CME) with a Market Perform and raises the price targ...
Barclays analyst Benjamin Budish maintains CME Gr (NASDAQ:CME) with a Equal-Weight and raises the price target from $208 to ...